CV Sciences Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
CVSI Over the counter 2833 https://cvsciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CV Sciences Inc

CV Sciences, Inc. Reports First Quarter 2022 Financial Results - May 16th, 2022 1:00 pm
CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022 - May 12th, 2022 11:00 am
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results - Mar 31st, 2022 8:05 pm
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022 - Mar 28th, 2022 8:05 pm
UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products - Mar 11th, 2022 5:59 pm
CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products - Mar 8th, 2022 2:11 pm
CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals - Jan 11th, 2022 1:00 pm
CV Sciences, Inc. Announces New Distribution Agreement with GNC - Jan 5th, 2022 1:00 pm
CV Sciences, Inc. Appoints Haskell & White LLP as Auditor - Nov 30th, 2021 9:30 pm
Here's Why CV Sciences, Inc. (CVSI) Looks Ripe for Bottom Fishing - Nov 23rd, 2021 3:00 pm
CV Sciences, Inc. Announces Convertible Note Financing - Nov 15th, 2021 1:25 pm
CV Sciences, Inc. Reports Third Quarter 2021 Financial Results - Nov 15th, 2021 1:05 pm
CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021 - Nov 8th, 2021 1:00 pm
Will CV Sciences, Inc. (CVSI) Report Negative Q3 Earnings? What You Should Know - Oct 28th, 2021 7:05 pm
CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45 - Oct 7th, 2021 5:01 pm
CV Sciences, Inc. Reports Second Quarter 2021 Financial Results - Aug 12th, 2021 8:05 pm
CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021 - Aug 5th, 2021 12:00 pm
CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award - Jul 27th, 2021 12:00 pm
CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence - Jul 20th, 2021 12:00 pm